Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 936865, 8 pages
http://dx.doi.org/10.1155/2015/936865
Research Article

Deep Brain Stimulation Can Preserve Working Status in Parkinson’s Disease

1Department of Neurology, University of Pécs, Rét Utca 2, Pécs 7623, Hungary
2Department of Neurosurgery, University of Pécs, Rét Utca 2, Pécs 7623, Hungary
3MTA-PTE Clinical Neuroscience MR Research Group, Rét Utca 2, Pécs 7623, Hungary
4Department of Neurology, Kaposi Mór County Hospital, Tallián Gyula Utca 16, Kaposvár 7400, Hungary

Received 30 April 2015; Revised 8 July 2015; Accepted 16 July 2015

Academic Editor: Eng-King Tan

Copyright © 2015 Gabriella Deli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Kovacs, I. Balas, J. Janszky et al., “Special aspects of patient care after implantation of deep-brain-stimulator,” Ideggyógyászati Szemle, vol. 61, pp. 4–15, 2008. View at Google Scholar
  2. G. Deuschl, C. Schade-Brittinger, P. Krack et al., “A randomized trial of deep-brain stimulation for Parkinson's disease,” The New England Journal of Medicine, vol. 355, no. 9, pp. 896–908, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Deli, I. Balás, S. Komoly et al., “Treatment of dystonia by deep brain stimulation: a summary of 40 cases,” Ideggyogyaszati Szemle, vol. 65, no. 7-8, pp. 249–260, 2012. View at Google Scholar · View at Scopus
  4. Z. Aschermann, N. Kovacs, and S. Komoly, “Continuous dopaminergic stimulation in Parkinson disease: possibilities in 2013,” Ideggyógyászati Szemle, vol. 66, pp. 209–210, 2013. View at Google Scholar
  5. G. Kleiner-Fisman, J. Herzog, D. N. Fisman et al., “Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes,” Movement Disorders, vol. 21, supplement 14, pp. S290–S304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Fehér, I. Balás, S. Komoly et al., “A kétoldali szubtalamikus stimuláció hatékonysága az antiparkinson gyógyszerelés változtatásának tükrében,” Ideggyógyászati Szemle, vol. 63, pp. 314–319, 2010. View at Google Scholar
  7. G. Tamás, A. Takáts, P. Radics et al., “A mély agyi stimuláció hatékonysága Parkinson-kóros betegeink kezelésébenz,” Ideggyógyászati Szemle, vol. 66, pp. 115–120, 2013. View at Google Scholar
  8. M. C. Rodriguez-Oroz, E. Moro, and P. Krack, “Long-term outcomes of surgical therapies for Parkinson's disease,” Movement Disorders, vol. 27, no. 14, pp. 1718–1728, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Fasano, L. M. Romito, A. Daniele et al., “Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants,” Brain, vol. 133, no. 9, pp. 2664–2676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Horstink, E. Tolosa, U. Bonuccelli et al., “Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease,” European Journal of Neurology, vol. 13, no. 11, pp. 1170–1185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Kovács, B. István, L. Carlos et al., “Deep brain stimulation: a breakthrough in the treatment of movement disorders,” Lege Artis Medicinae, vol. 19, no. 2, pp. 119–126, 2009. View at Google Scholar · View at Scopus
  12. W. M. M. Schüpbach, D. Maltête, J. L. Houeto et al., “Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial,” Neurology, vol. 68, no. 4, pp. 267–271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. E. Lang, J.-L. Houeto, P. Krack et al., “Deep brain stimulation: preoperative issues,” Movement Disorders, vol. 21, supplement 14, pp. S171–S196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. A. E. Lang, “Subthalamic stimulation for Parkinson's disease—living better electrically?” The New England Journal of Medicine, vol. 349, no. 20, pp. 1888–1891, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. W. M. M. Schuepbach, J. Rau, K. Knudsen et al., “Neurostimulation for Parkinson's disease with early motor complications,” The New England Journal of Medicine, vol. 368, no. 7, pp. 610–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. W. M. M. Schüpbach, J. Rau, J.-L. Houeto et al., “Myths and facts about the EARLYSTIM study,” Movement Disorders, vol. 29, no. 14, pp. 1742–1750, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Deuschl, M. Schüpbach, K. Knudsen et al., “Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study,” Parkinsonism and Related Disorders, vol. 19, no. 1, pp. 56–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. A. Mestre, A. J. Espay, C. Marras, M. H. Eckman, P. Pollak, and A. E. Lang, “Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease—the EARLYSTIM trial: early is not always better,” Movement Disorders, vol. 29, no. 14, pp. 1751–1756, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Keitel, S. Ferrea, M. Südmeyer, A. Schnitzler, and L. Wojtecki, “Expectation modulates the effect of deep brain stimulation on motor and cognitive function in tremor-dominant Parkinson's disease,” PLoS ONE, vol. 8, no. 12, Article ID e81878, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Litvan, K. P. Bhatia, D. J. Burn et al., “SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders,” Movement Disorders, vol. 18, no. 5, pp. 467–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Kaszás, N. Kovács, I. Balás et al., “Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 18, no. 5, pp. 553–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Szende and R. Németh, “Health-related quality of life of the Hungarian population,” Orvosi Hetilap, vol. 144, no. 34, pp. 1667–1674, 2003. View at Google Scholar · View at Scopus
  23. J. Dams, J. Klotsche, B. Bornschein et al., “Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson's disease,” Health and Quality of Life Outcomes, vol. 11, article 35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Luo, W.-Y. Ng, P.-N. Lau, W.-L. Au, and L. C. S. Tan, “Responsiveness of the EQ-5D and 8-item Parkinson's disease questionnaire (PDQ-8) in a 4-year follow-up study,” Quality of Life Research, vol. 19, no. 4, pp. 565–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Schrag, C. Selai, M. Jahanshahi, and N. P. Quinn, “The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 69, no. 1, pp. 67–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Bokor and A. Szentesi, “The effect of Stalevo-dosing on quality of life of Parkinsonian patients with wearing-off,” Ideggyogyaszati Szemle, vol. 63, no. 7-8, pp. 247–251, 2010. View at Google Scholar · View at Scopus
  27. P. Klivényi and L. Vécsei, “The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life,” Ideggyógyászati Szemle, vol. 61, no. 1-2, pp. 42–48, 2008. View at Google Scholar · View at Scopus
  28. J. Dams, U. Siebert, B. Bornschein et al., “Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease,” Movement Disorders, vol. 28, no. 6, pp. 763–771, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Kovács, Z. Aschermann, P. Ács et al., “The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease,” Ideggyogyaszati Szemle, vol. 67, no. 7-8, pp. 245–250, 2014. View at Google Scholar · View at Scopus
  30. S. Fahn and R. Elton, “Unified Parkinson's disease rating scale,” in Recent Developments in Parkinson's Disease, S. Fahn, C. Marsden, M. Goldstein, and D. Calne, Eds., pp. 153–163, 293–304, Macmillan Healthcare Information, Florham Park, NJ, USA, 1987. View at Google Scholar
  31. C. G. Goetz, W. Poewe, O. Rascol et al., “Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations,” Movement Disorders, vol. 19, no. 9, pp. 1020–1028, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Schwab and A. England, “Projection technique for evaluating surgery in Parkinson's disease,” in Proceedings of the 3rd Symposium on Parkinson's Disease, F. Gillingham and M. Donaldson, Eds., pp. 152–157, E & S Livingston, Edinburgh, Scotland, 1969.
  33. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. V. Glass, P. D. Peckham, and J. R. Sanders, “Consequences of failure to meet assumptions underlying fixed effects analyses of variance and covariance,” Review of Educational Research, vol. 42, no. 3, pp. 237–288, 1972. View at Publisher · View at Google Scholar
  35. M. R. Harwell, E. N. Rubinstein, W. S. Hayes, and C. C. Olds, “Summarizing Monte Carlo results in methodological research: the one- and two-factor fixed effects ANOVA cases,” Journal of Educational Statistics, vol. 17, no. 4, pp. 315–339, 1992. View at Publisher · View at Google Scholar
  36. L. M. Lix, J. C. Keselman, and H. J. Keselman, “Consequences of assumption violations revisited: a quantitative review of alternatives to the one-way analysis of variance F test,” Review of Educational Research, vol. 66, no. 4, pp. 579–619, 1996. View at Google Scholar · View at Scopus